| Variation | | Type (Consequence) | Condition | Classification, Review status |
---|
| | JAK2, INSL6 (R564L +2 more) | Single nucleotide variant (missense variant +1 more) | not provided | |
| | INSL6, JAK2 (V617F +2 more) | Single nucleotide variant (missense variant +1 more) | not provided +6 more | GPathogenic/Likely pathogenic |
| | INSL6, JAK2 (R683G +2 more) | Single nucleotide variant (missense variant +1 more) | Myeloproliferative disorder +1 more | GPathogenic/Likely pathogenic |
| | INSL6, JAK2 (R683T +2 more) | Single nucleotide variant (missense variant +1 more) | Lymphoblastic leukemia, acute, with lymphomatous features | |
| | INSL6, JAK2 (R683S +2 more) | Single nucleotide variant (missense variant +1 more) | Lymphoblastic leukemia, acute, with lymphomatous features | |
| | INSL6, JAK2 (R683S +2 more) | Single nucleotide variant (missense variant +1 more) | Lymphoblastic leukemia, acute, with lymphomatous features | |
| | INSL6, JAK2 (T875N +2 more) | Single nucleotide variant (missense variant +1 more) | Myeloproliferative disorder | |
Click to view in NCBI Gene